-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
sipavibart
-
Still to open [Fort Lauderdale, Florida, USA] SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Effectiveness of Treating Post-COVID-19 Conditions (Long COVID) With the SARS-CoV-2 Specific Monoclonal Antibody, Sipavibart Brief Summary This placebo-controlled, randomized, blinded, two-arm phase II study will test the safety and potential efficacy of the targeted mAb, Sipavibart (formerly...- forestglip
- Thread
- klimas long covid
- Replies: 1
- Forum: Recruitment into current ME/CFS research studies